1982
DOI: 10.1055/s-2007-1005048
|View full text |Cite
|
Sign up to set email alerts
|

Platelet Destruction in Renal Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

1983
1983
2012
2012

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 140 publications
(185 reference statements)
0
6
0
Order By: Relevance
“…To this end, anti-endothelial cell antibodies have been suggested as etiologic in TTP, although their presence remains controversial (41,47). Another example of primary endothelial cell injury which can lead to renal damage is that occurring with anti-phospholipid antibodies; while in this disease activation of the clotting cascade is typical, a TTP-like picture can also result (48).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To this end, anti-endothelial cell antibodies have been suggested as etiologic in TTP, although their presence remains controversial (41,47). Another example of primary endothelial cell injury which can lead to renal damage is that occurring with anti-phospholipid antibodies; while in this disease activation of the clotting cascade is typical, a TTP-like picture can also result (48).…”
Section: Discussionmentioning
confidence: 99%
“…However, the control animals preimmunized with mouse IgG and given normal mouse IgG also had lowered platelet counts. Presumably, this reflects the development of acute serum sickness, with its effects on platelets (40,41). Interestingly, animals preimmunized with normal mouse IgG had deposition of mouse and rat IgG in the glomerular mesangium, likely reflecting deposition of circulating immune complexes of mouse and rat IgG (Fig.…”
Section: K6/1-induced Thrombocytopenia and Anemiamentioning
confidence: 95%
“…Physical destruction of platelets may occur because of intravascular catheters. 67 Thrombocytopenia and platelet dysfunction are commonly seen in liver disease, paraproteinemia, myeloproliferative disorders, and myelodysplastic syndrome. 66,67 Thrombocytopenia may be found in patients receiving nicotinamide for treatment of cholesterol abnormalities or hyperphosphatemia, 68 and many drugs sometimes taken by hemodialysis patients, including clopidogrel and other antiplatelet agents, as well as quinine, for example, can cause drug-induced thrombocytopenia.…”
Section: Thrombocytopenia In Dialysis Patientsmentioning
confidence: 99%
“…67 Thrombocytopenia and platelet dysfunction are commonly seen in liver disease, paraproteinemia, myeloproliferative disorders, and myelodysplastic syndrome. 66,67 Thrombocytopenia may be found in patients receiving nicotinamide for treatment of cholesterol abnormalities or hyperphosphatemia, 68 and many drugs sometimes taken by hemodialysis patients, including clopidogrel and other antiplatelet agents, as well as quinine, for example, can cause drug-induced thrombocytopenia. 69 Finally, in actively bleeding patients, dilutional thrombocytopenia can occur when transfusing packed red blood cells (RBCs) only, as functional platelets are not present in packed RBC transfusions.…”
Section: Thrombocytopenia In Dialysis Patientsmentioning
confidence: 99%
“…In creased capillary fragility and thrombocytopenia [1] as well as increased platelet destruction [2] have been described in certain renal disorders. In addition, de creased prothrombin consumption, diminished plate let factor 3 availability, abnormal platelet adhesive ness and aggregation, low serotonin content and poor clot retraction found in patients with CRF [3] served as an additional explanation for the hemostatic de fects.…”
mentioning
confidence: 99%